Zevra therapeutics will participate in rbc capital markets global healthcare conference on may 16, 2023

Celebration, fla., may 10, 2023 (globe newswire) -- zevra therapeutics, inc. (nasdaqgs: zvra) (“zevra” or the “company” and formerly kempharm, inc.), a rare disease therapeutics company, today announced that r. laduane clifton, the company's chief financial officer, will present at the rbc capital markets global healthcare conference on tuesday, may 16, 2023, at 3:05 p.m. et. in addition, members of zevra's management team will be available for one-on-one investor meetings with registered attendees during the conference from may 16-17, 2023.
ZVRA Ratings Summary
ZVRA Quant Ranking